Merck 'bio-inks' deal to use Organovo's 3D printed liver for preclinical studies
Merck & Co. has struck a deal with Organovo to use a 3D printed human liver system for toxicology testing as a supplement to in vitro and preclinical animal testing.
Merck & Co. has struck a deal with Organovo to use a 3D printed human liver system for toxicology testing as a supplement to in vitro and preclinical animal testing.
Juniper has received a licence to make unlicensed medicinal products – or ‘Specials’ – but will only produce batches with relatively high volumes to keep clients’ costs down.
A small molecule combination therapy has shown promise in defeating breast cancers resistant to the usual treatments.
Dispatches from PCT US
As sponsors and CROs continue the inevitable shift away from 100% SDV (source data verification) in line with US FDA and TransCelerate guidance, new risk-based monitoring (RBM) strategies are cropping up in various ways across the industry.
Agilent Technologies has launched a quadrupole-time of flight (Q-TOF) mass spectrometry system for applications including food safety and pharmaceuticals.
Technology transfer is the first step to bringing pharma investments to Africa, says the African Regulatory Network (ARN).
Special from BPI Europe 2015
Pfizer reduced costs 40% without cutting jobs at a facility in Sweden using an alternative approach to organisational and cultural behaviour, and hopes to do the same at its newly acquired Austrian plant.